<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">36943067</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA.</ArticleTitle><Pagination><StartPage>e0415922</StartPage><MedlinePgn>e0415922</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e04159-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.04159-22</ELocationID><Abstract><AbstractText>Most individuals acutely infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit mild symptoms. However, 10 to 20% of those infected develop long-term symptoms, referred to as post-coronavirus disease 2019 (COVID-19) condition (PCC). One hypothesis is that PCC might be exacerbated by viral persistence in tissue sanctuaries. Therefore, the accurate detection and quantification of SARS-CoV-2 are not only necessary for viral load monitoring but also crucial for detecting long-term viral persistence and determining whether viral replication is occurring in tissue reservoirs. In this study, the sensitivity and robustness of reverse transcription (RT)-droplet digital PCR (ddPCR) and RT-quantitative PCR (qPCR) techniques have been compared for the detection and quantification of SARS-CoV-2 genomic and subgenomic RNAs from oropharyngeal swabs taken from confirmed SARS-CoV-2-positive, SARS-CoV-2-exposed, and nonexposed individuals as well as from samples from mice infected with SARS-CoV-2. Our data demonstrated that both techniques presented equivalent results in the mid- and high-viral-load ranges. Additionally, RT-ddPCR was more sensitive than RT-qPCR in the low-viral-load range, allowing the accurate detection of positive results in individuals exposed to the virus. Overall, these data suggest that RT-ddPCR might be an alternative to RT-qPCR for detecting low viral loads in samples and for assessing viral persistence in samples from individuals with PCC. <b>IMPORTANCE</b> We developed one-step reverse transcription (RT)-droplet digital PCR (ddPCR) protocols to detect SARS-CoV-2 RNA and compared them to the gold-standard RT-quantitative PCR (RT-qPCR) method. RT-ddPCR was more sensitive than RT-qPCR in the low-viral-load range, while both techniques were equivalent in the mid- and high-viral-load ranges. Overall, these results suggest that RT-ddPCR might be a viable alternative to RT-qPCR when it comes to detecting low viral loads in samples, which is a highly relevant issue for determining viral persistence in as-yet-unknown tissue reservoirs in individuals suffering from post-COVID conditions or long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mor&#xf3;n-L&#xf3;pez</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0800-9205</Identifier><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Enfermedades Infecciosas, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riveira-Mu&#xf1;oz</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urrea</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Chamorro</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;vila-Nieto</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noguera-Julian</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6194-1395</Identifier><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Enfermedades Infecciosas, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Enfermedades Infecciosas, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitj&#xe0;</LastName><ForeName>Oriol</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Fight Infections Foundation, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias i Pujol, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lihir Medical Centre, International SOS, Londolovit, Lihir Island, Papua New Guinea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateu</LastName><ForeName>Lourdes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fight Infections Foundation, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias i Pujol, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Autonomous University of Barcelona (UAB), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massanella</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Enfermedades Infecciosas, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballana</LastName><ForeName>Ester</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5215-7363</Identifier><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Picado</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4916-2129</Identifier><AffiliationInfo><Affiliation>IrsiCaixa AIDS Research Institute, Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER de Enfermedades Infecciosas, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Microbiol Spectr. 2024 Oct 30:e0226924. doi: 10.1128/spectrum.02269-24</RefSource><PMID Version="1">39475270</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RT-ddPCR</Keyword><Keyword MajorTopicYN="N">RT-qPCR</Keyword><Keyword MajorTopicYN="N">genomic SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">subgenomic SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">viral persistence</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36943067</ArticleId><ArticleId IdType="pmc">PMC10100669</ArticleId><ArticleId IdType="doi">10.1128/spectrum.04159-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institutes of Health. 29
August
2020, access date. COVID-19 treatment guidelines: clinical spectrum of SARS-CoV-2 infection.
National Institutes of Health, Bethesda, MD. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.</Citation></Reference><Reference><Citation>World Health Organization. 2021. Coronavirus disease (COVID-19): post COVID-19 condition.
World Health Organization, Geneva, Switzerland. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition. Accessed 29 August 2022.</Citation></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative . 2022. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400:452&#x2013;461. doi:10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, Tan B, Tay ZEA, Wan WY, Chen EX, Nerurkar SN, Loong S, Cheow PC, Chan CY, Koh YX, Tan TT, Kalimuddin S, Tai WMD, Ng JL, Low JG-H, Yeong J, Lim KH. 2022. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71:226&#x2013;229. doi:10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D, Lim JCT, Fernandez SB, Lee JN, Joseph CR, Neo ZW, Guerrero S, Lau MC, Sheng JYP. 2022. Persistence of residual SARS-CoV-2 viral antigen and RNA in tissues of patients with long COVID-19. Res Sq doi:10.21203/rs.3.rs-1379777/v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1379777/v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Alteri C, Cento V, Antonello M, Colagrossi L, Merli M, Ughi N, Renica S, Matarazzo E, Di Ruscio F, Tartaglione L, Colombo J, Grimaldi C, Carta S, Nava A, Costabile V, Baiguera C, Campisi D, Fanti D, Vismara C, Fumagalli R, Scaglione F, Epis OM, Puoti M, Perno CF. 2020. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients. PLoS One 15:e0236311. doi:10.1371/journal.pone.0236311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236311</ArticleId><ArticleId IdType="pmc">PMC7478621</ArticleId><ArticleId IdType="pubmed">32898153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed W, Smith WJM, Metcalfe S, Jackson G, Choi PM, Morrison M, Field D, Gyawali P, Bivins A, Bibby K, Simpson SL. 2022. Comparison of RT-qPCR and RT-dPCR platforms for the trace detection of SARS-CoV-2 RNA in wastewater. ACS ES T Water 2:1871&#x2013;1880. doi:10.1021/acsestwater.1c00387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsestwater.1c00387</ArticleId><ArticleId IdType="pmc">PMC8848507</ArticleId><ArticleId IdType="pubmed">36380768</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassinari K, Alessandri-Gradt E, Chambon P, Charbonnier F, Gracias S, Beaussire L, Alexandre K, Sarafan-Vasseur N, Houdayer C, Etienne M, Caron F, Plantier JC, Frebourg T. 2021. Assessment of multiplex digital droplet RT-PCR as a diagnostic tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples. Clin Chem 67:736&#x2013;741. doi:10.1093/clinchem/hvaa323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa323</ArticleId><ArticleId IdType="pmc">PMC7799276</ArticleId><ArticleId IdType="pubmed">33331864</ArticleId></ArticleIdList></Reference><Reference><Citation>Lock M, McGorray S, Auricchio A, Ayuso E, Beecham EJ, Blouin-Tavel V, Bosch F, Bose M, Byrne BJ, Caton T, Chiorini JA, Chtarto A, Clark KR, Conlon T, Darmon C, Doria M, Douar A, Flotte TR, Francis JD, Francois A, Giacca M, Korn MT, Korytov I, Leon X, Leuchs B, Lux G, Melas C, Mizukami H, Moullier P, M&#xfc;ller M, Ozawa K, Philipsberg T, Poulard K, Raupp C, Rivi&#xe8;re C, Roosendaal SD, Samulski RJ, Soltys SM, Surosky R, Tenenbaum L, Thomas DL, van Montfort B, Veres G, Wright JF, Xu Y, Zelenaia O, Zentilin L, Snyder RO. 2010. Characterization of a recombinant adeno-associated virus type 2 reference standard material. Hum Gene Ther 21:1273&#x2013;1285. doi:10.1089/hum.2009.223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2009.223</ArticleId><ArticleId IdType="pmc">PMC2957240</ArticleId><ArticleId IdType="pubmed">20486768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso E, Blouin V, Lock M, McGorray S, Leon X, Alvira MR, Auricchio A, Bucher S, Chtarto A, Clark KR, Darmon C, Doria M, Fountain W, Gao G, Gao K, Giacca M, Kleinschmidt J, Leuchs B, Melas C, Mizukami H, M&#xfc;ller M, Noordman Y, Bockstael O, Ozawa K, Pythoud C, Sumaroka M, Surosky R, Tenenbaum L, van der Linden I, Weins B, Wright JF, Zhang X, Zentilin L, Bosch F, Snyder RO, Moullier P. 2014. Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Hum Gene Ther 25:977&#x2013;987. doi:10.1089/hum.2014.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2014.057</ArticleId><ArticleId IdType="pmc">PMC4236062</ArticleId><ArticleId IdType="pubmed">25275822</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutsaert S, Bosman K, Trypsteen W, Nijhuis M, Vandekerckhove L. 2018. Digital PCR as a tool to measure HIV persistence. Retrovirology 15:16. doi:10.1186/s12977-018-0399-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-018-0399-0</ArticleId><ArticleId IdType="pmc">PMC5789538</ArticleId><ArticleId IdType="pubmed">29378600</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Aguirre I, Ra&#x10d;ki N, Dreo T, Ravnikar M. 2015. Droplet digital PCR for absolute quantification of pathogens. Methods Mol Biol 1302:331&#x2013;347. doi:10.1007/978-1-4939-2620-6_24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2620-6_24</ArticleId><ArticleId IdType="pubmed">25981265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazaika E, Homsy J. 2014. Digital droplet PCR: CNV analysis and other applications. Curr Protoc Hum Genet 82:7.24.1&#x2013;7.24.13. doi:10.1002/0471142905.hg0724s82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142905.hg0724s82</ArticleId><ArticleId IdType="pmc">PMC4355013</ArticleId><ArticleId IdType="pubmed">25042719</ArticleId></ArticleIdList></Reference><Reference><Citation>Long S. 2021. SARS-CoV-2 subgenomic RNAs: characterization, utility, and perspectives. Viruses 13:1923. doi:10.3390/v13101923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101923</ArticleId><ArticleId IdType="pmc">PMC8539008</ArticleId><ArticleId IdType="pubmed">34696353</ArticleId></ArticleIdList></Reference><Reference><Citation>Telwatte S, Kumar N, Vallejo-Gracia A, Kumar GR, Lu CM, Ott M, Wong JK, Yukl SA. 2021. Novel RT-ddPCR assays for simultaneous quantification of multiple noncoding and coding regions of SARS-CoV-2 RNA. J Virol Methods 292:114115. doi:10.1016/j.jviromet.2021.114115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114115</ArticleId><ArticleId IdType="pmc">PMC7923865</ArticleId><ArticleId IdType="pubmed">33667568</ArticleId></ArticleIdList></Reference><Reference><Citation>Telwatte S, Martin HA, Marczak R, Fozouni P, Vallejo-Gracia A, Kumar GR, Murray V, Lee S, Ott M, Wong JK, Yukl SA. 2022. Novel RT-ddPCR assays for measuring the levels of subgenomic and genomic SARS-CoV-2 transcripts. Methods 201:15&#x2013;25. doi:10.1016/j.ymeth.2021.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105137</ArticleId><ArticleId IdType="pubmed">33882362</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Br&#xfc;nink S, Schneider J, Schmidt ML, Mulders DGJC, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette J-L, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MPG, Drosten C. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25:2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvia R, Sollai M, Pierucci F, Urso C, Massi D, Zakrzewska K. 2017. Droplet digital PCR (ddPCR) vs quantitative real-time PCR (qPCR) approach for detection and quantification of Merkel cell polyomavirus (MCPyV) DNA in formalin fixed paraffin embedded (FFPE) cutaneous biopsies. J Virol Methods 246:15&#x2013;20. doi:10.1016/j.jviromet.2017.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2017.04.003</ArticleId><ArticleId IdType="pubmed">28414163</ArticleId></ArticleIdList></Reference><Reference><Citation>Yukl SA, Kaiser P, Kim P, Telwatte S, Joshi SK, Vu M, Lampiris H, Wong JK. 2018. HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Sci Transl Med 10:eaap9927. doi:10.1126/scitranslmed.aap9927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aap9927</ArticleId><ArticleId IdType="pmc">PMC5959841</ArticleId><ArticleId IdType="pubmed">29491188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bivins A, Kaya D, Bibby K, Simpson SL, Bustin SA, Shanks OC, Ahmed W. 2021. Variability in RT-qPCR assay parameters indicates unreliable SARS-CoV-2 RNA quantification for wastewater surveillance. Water Res 203:117516. doi:10.1016/j.watres.2021.117516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.watres.2021.117516</ArticleId><ArticleId IdType="pmc">PMC8341816</ArticleId><ArticleId IdType="pubmed">34412018</ArticleId></ArticleIdList></Reference><Reference><Citation>Svec D, Tichopad A, Novosadova V, Pfaffl MW, Kubista M. 2015. How good is a PCR efficiency estimate: recommendations for precise and robust qPCR efficiency assessments. Biomol Detect Quantif 3:9&#x2013;16. doi:10.1016/j.bdq.2015.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bdq.2015.01.005</ArticleId><ArticleId IdType="pmc">PMC4822216</ArticleId><ArticleId IdType="pubmed">27077029</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;arrubia L, Ruiz M, Porco R, Rao SN, Juanola-Falgarona M, Manissero D, L&#xf3;pez-Fontanals M, Pareja J. 2020. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak. Int J Infect Dis 97:225&#x2013;229. doi:10.1016/j.ijid.2020.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.027</ArticleId><ArticleId IdType="pmc">PMC7289722</ArticleId><ArticleId IdType="pubmed">32535302</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogels CBF, Brito AF, Wyllie AL, Fauver JR, Ott IM, Kalinich CC, Petrone ME, Casanovas-Massana A, Catherine Muenker M, Moore AJ, Klein J, Lu P, Lu-Culligan A, Jiang X, Kim DJ, Kudo E, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Tokuyama M, Venkataraman A, Weizman O-E, Wong P, Yang Y, Cheemarla NR, White EB, Lapidus S, Earnest R, Geng B, Vijayakumar P, Odio C, Fournier J, Bermejo S, Farhadian S, Dela Cruz CS, Iwasaki A, Ko AI, Landry ML, Foxman EF, Grubaugh ND. 2020. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets. Nat Microbiol 5:1299&#x2013;1305. doi:10.1038/s41564-020-0761-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0761-6</ArticleId><ArticleId IdType="pmc">PMC9241364</ArticleId><ArticleId IdType="pubmed">32651556</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao AT, Tong YX, Zhang S. 2020. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Clin Infect Dis 71:2249&#x2013;2251. doi:10.1093/cid/ciaa460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa460</ArticleId><ArticleId IdType="pmc">PMC7188124</ArticleId><ArticleId IdType="pubmed">32306036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054&#x2013;1062. doi:10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, Xie G, Lin S, Wang R, Yang X, Chen W, Wang Q, Zhang D, Liu Y, Gong R, Ma Z, Lu S, Xiao Y, Gu Y, Zhang J, Yao H, Xu K, Lu X, Wei G, Zhou J, Fang Q, Cai H, Qiu Y, Sheng J, Chen Y, Liang T. 2020. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 369:m1443. doi:10.1136/bmj.m1443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1443</ArticleId><ArticleId IdType="pmc">PMC7190077</ArticleId><ArticleId IdType="pubmed">32317267</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, Barbian K, Judson SD, Fischer ER, Martens C, Bowden TA, de Wit E, Riedo FX, Munster VJ. 2020. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 183:1901&#x2013;1912.e9. doi:10.1016/j.cell.2020.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.049</ArticleId><ArticleId IdType="pmc">PMC7640888</ArticleId><ArticleId IdType="pubmed">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo H-H, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY-T, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ. 2020. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med 383:2291&#x2013;2293. doi:10.1056/NEJMc2031364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Baang JH, Smith C, Mirabelli C, Valesano AL, Manthei DM, Bachman MA, Wobus CE, Adams M, Washer L, Martin ET, Lauring AS. 2021. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient. J Infect Dis 223:23&#x2013;27. doi:10.1093/infdis/jiaa666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa666</ArticleId><ArticleId IdType="pmc">PMC7797758</ArticleId><ArticleId IdType="pubmed">33089317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp SA, Collier DA, Datir RP, Ferreira IATM, Gayed S, Jahun A, Hosmillo M, Rees-Spear C, Mlcochova P, Lumb IU, Roberts DJ, Chandra A, Temperton N, CITIID-NIHR BioResource COVID-19 Collaboration, COVID-19 Genomics UK (COG-UK) Consortium, Sharrocks K, Blane E, Modis Y, Leigh KE, Briggs JAG, van Gils MJ, Smith KGC, Bradley JR, Smith C, Doffinger R, Ceron-Gutierrez L, Barcenas-Morales G, Pollock DD, Goldstein RA, Smielewska A, Skittrall JP, Gouliouris T, Goodfellow IG, Gkrania-Klotsas E, Illingworth CJR, McCoy LE, Gupta RK. 2021. SARS-CoV-2 evolution during treatment of chronic infection. Nature 592:277&#x2013;282. doi:10.1038/s41586-021-03291-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, Yinda CK, Winkler CW, Sun J, Dickey JM, Ylaya K, Ko SH, Platt AP, Burbelo PD, Quezado M, Pittaluga S, Purcell M, Munster VJ, Belinky F, Ramos-Benitez MJ, Boritz EA, Lach IA, Herr DL, Rabin J, Saharia KK, Madathil RJ, Tabatabai A, Soherwardi S, McCurdy MT, NIH COVID-19 Autopsy Consortium, Peterson KE, Cohen JI, de Wit E, Vannella KM, Hewitt SM, Kleiner DE, Chertow DS. 2022. SARS-CoV-2 infection and persistence throughout the human body and brain at autopsy. Nature 612:758&#x2013;763. doi:10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, H&#xe4;ggl&#xf6;f T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O&#x2019;Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC. 2021. Evolution of antibody immunity to SARS-CoV-2. Nature 591:639&#x2013;644. doi:10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J, Moron-Lopez S, Dalmau J, Gonzalez-Aumatell A, Carreras-Abad C, Mendez M, Rodrigo C, Martinez-Picado J. 2022. Post COVID-19 condition in children and adolescents: an emerging problem. Front Pediatr 10:894204. doi:10.3389/fped.2022.894204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, Primus-de Jong C, Cleemput I, Van den Heede K. 2022. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 54:1473&#x2013;1487. doi:10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>